Abera Bioscience AB news
Abera Bioscience AB is a biotechnology company that develops vaccine candidates based on patented vaccine platforms. The latest vaccine platform makes it possible to produce single, or multiple, antigens in so-called protein bodies. Antigens are the pathogen-specific components of vaccines that elicit immune responses. Protein bodies are nano-sized protein particles.
The company is now entering into a partnership with an American university to drive the development of a vaccine candid
Abera Bioscience AB receives a grant from Vinnova, Sweden’s innovation agency, of SEK 400,000 within the call “Preparatory project for international application in health 2021”. Abera intends to attract the leading experts in the field and build a competitive consortium and project for the development of vaccines based on the company’s platforms to attract funding from the EU’s international health call next year. The grant from Vinnova aims at activities to stre
Abera Bioscience AB receives a grant from Vinnova, Sweden’s innovation agency, of SEK 400,000 within the call “Preparatory project for international application in health 2021”. Abera intends to attract the leading experts in the field and build a competitive consortium and project for the development of vaccines based on the company’s platforms to attract funding from the EU’s international health call next year. The grant from Vinnova aims at activities to stre
Abera Bioscience AB has received so-called Notice of Allowance of the company’s patent application “ Fusion polypeptides comprising one or more inclusion body tags, methods and uses ” by the US Patent Office (USPTO). The patent forms the basis of a new vaccine platform that the company has developed in parallel with existing platforms. It entails technology that allows the efficient production of d
Abera Bioscience AB (“Abera” or “the Company”) continues to improve its vaccine platform in collaboration with researchers at Vrije Universiteit Amsterdam. An article was recently published in the peer-reviewed journal Microbial Cell Factories by researchers Trang H. Phan, Coen Kuijl and Peter van Ulsen of Vrije Universiteit Amsterdam in collaboration with Abera’s Dung T. Huynh, Wouter S.P. Jong and Joen Luirink. The authors identified ways to improve the